logo PX'Therapeutics
Our Development Strategy

To sustain our development, we plan to integrate complementary technologies and multiply our production capacities. The recent collaboration with Althea Technologies now allows us to propose large scale manufacturing capabilities for phase I to III clinical trials and market production in bacterial and yeast systems. In addition, we plan to set up a new cGMP manufacturing unit dedicated to preclinical and clinical manufacturing in mammalian cells.

We also work at strengthening our global presence and are currently opening an office in Boston (United States).



Zone Minatec Entreprises - 7 parvis Louis Néel - BP50 F 38040 Grenoble
Phone: +33(0)438 023 650 - Fax: +33(0)438 961 038